These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent. Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970 [TBL] [Abstract][Full Text] [Related]
4. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis. Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096 [TBL] [Abstract][Full Text] [Related]
5. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types. Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426 [TBL] [Abstract][Full Text] [Related]
6. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency. Barkin JA; Harb D; Kort J; Barkin JS Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440 [TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on the Epidemiology, Evaluation, and Management of Exocrine Pancreatic Insufficiency: Expert Review. Whitcomb DC; Buchner AM; Forsmark CE Gastroenterology; 2023 Nov; 165(5):1292-1301. PubMed ID: 37737818 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis. Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243 [TBL] [Abstract][Full Text] [Related]
9. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency. Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255 [TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study. Roberts KJ; Bannister CA; Schrem H Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188 [TBL] [Abstract][Full Text] [Related]
11. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients. Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656 [TBL] [Abstract][Full Text] [Related]
12. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes. Lewis DM; Shahid A J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705 [TBL] [Abstract][Full Text] [Related]
13. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials. Ammar K; Leeds JS; Ratnayake CB; Sen G; French JJ; Nayar M; Oppong KW; Loveday BP; Pandanaboyana S Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):941-948. PubMed ID: 33522321 [No Abstract] [Full Text] [Related]
14. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study. Graff GR; McNamara J; Royall J; Caras S; Forssmann K Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244 [TBL] [Abstract][Full Text] [Related]
15. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency. Kuhn RJ; Gelrud A; Munck A; Caras S Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management. Dunleavy L; Al-Mukhtar A; Halliday V Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691 [TBL] [Abstract][Full Text] [Related]
17. The Population-Level Prevalence of Exocrine Pancreas Insufficiency and the Subsequent Risk of Pancreatic Cancer. Babajide O; Desai A; Eruchalu C; Sedarous M; Adekunle AD; Youssef M; Mahmud M; Okafor PN Pancreas; 2024 Oct; 53(9):e723-e728. PubMed ID: 38696443 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and Management. Carnie LE; Farrell K; Barratt N; Abraham M; Gillespie L; Satyadas T; McNamara MG; Hubner RA; Geraghty J; Bibby N; Valle JW; Lamarca A Pancreas; 2021 Oct; 50(9):1254-1259. PubMed ID: 34860808 [TBL] [Abstract][Full Text] [Related]
19. Effectivity of Pancreatic Enzyme Replacement Therapy in Malnourished Children. Güven B; Demir Mis M; Karaman K; Şahin Yaşar A J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):e114-e118. PubMed ID: 32443036 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis. de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R; Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]